top of page

Technology

Immune Topology

HLA-typing is essential for determining each patient's unique HLA type, which is critical for the immune system's ability to recognize and target cancer cells effectively.

Tumor Analysis

Our advanced RNA-sequencing of tumor samples enables the identification of highly expressed tumor antigens. This analysis also detects downregulated HLA alleles, a crucial factor in designing effective cancer vaccines and a unique advancement of our technology.

Vaccine Design

Our vaccine design process focuses on identifying putative peptide sequences that contain optimized amounts of highly immunogenic sections, known as epitopes. This ensures that our vaccines are tailored to elicit a strong and targeted immune response.

Relevant Publications

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

Clinically validated our VERDI cloud computing algortihm with the help of Aritifical Intelligence

A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine

Contact Us

bottom of page